Advancing HIV cure research in low- and middle-income countries requires empowerment of the next generation of scientists

Roger Tatoud; R Brad Jones; Krista Dong; Thumbi Ndung'u; Steven Deeks; Caroline T Tiemessen

doi:10.1016/j.jve.2024.100364

Advancing HIV cure research in low- and middle-income countries requires empowerment of the next generation of scientists

J Virus Erad. 2024 Mar 6;10(1):100364. doi: 10.1016/j.jve.2024.100364. eCollection 2024 Mar.

Authors

Roger Tatoud¹, R Brad Jones², Krista Dong³, Thumbi Ndung'u⁴, Steven Deeks⁵, Caroline T Tiemessen⁶

Affiliations

¹ Origena Consulting, Ferney Voltaire, France.
² Weill Cornell Medicine Graduate School of Medical Sciences, New York, USA.
³ Ragon Institute of MGH, Harvard Medical School, USA.
⁴ Africa Health Research Institute (AHRI), Durban, South Africa.
⁵ University of California, San Francisco, USA.
⁶ National Institute for Communicable Diseases, University of the Witwatersrand, Johannesburg, South Africa.

Abstract

While low- and middle-income countries (LMICs), especially in Southern and Eastern Africa, bear the largest burden of the HIV globally, investigators working on the front lines in these regions are leading a limited number of research efforts, particularly related to HIV cure. Conducting HIV cure research in high-burden HIV LIMCs provides an unparalleled opportunity to formulate innovative research strategies, design trials tailored to the local context, evaluate clinical outcomes within key and vulnerable populations, meaningful involvement of stakeholders, and to shape policies in areas where HIV prevention and cure interventions can yield the most significant impact. Further, the high prevalence of infection, with varied HIV strains affecting large diverse populations, creates a unique environment for studies that would not be feasible in any other part of the world. This underscores the critical importance of addressing obstacles to unlock the full potential of research efforts in these regions. In this viewpoint, we identify significant challenges facing early career investigators in LMICs, particularly in Africa, that hinder their full engagement in HIV cure research. Drawing examples from the International AIDS Society's Research-for-Cure Academy, we provide practical recommendations to overcome barriers that include limited access to funding, effective mentors, educational and career development opportunities, coupled with inadequate investment in infrastructure that contribute towards the limited number of investigators from high-burden HIV LIMCs who are spearheading cutting-edge cure research. Addressing these challenges is crucial to empower investigators who possess unique insights and expertise, and who are well positioned to lead HIV cure-related research efforts. We acknowledge and welcome initiatives that promote capacity building and knowledge exchange between early-career investigators in LMICs and their peers and scientific leaders from high-income countries (HICs). Prioritizing investment in global collaboration and partnership will play a pivotal role in empowering the next generation of African scientists and clinicians. To expedite advancements of cure-related strategies that will be effective in high-burden HIV LMICs, we endorse the sustainable expansion of these pivotal initiatives in these regions, to enhance their effectiveness and hasten progress in the pursuit of a global HIV cure.

Keywords: Africa; Early-career HIV researchers; HIV cure; Low- and middle-income countries; Research capacity; Research-for-Cure academy.